{"id":"interferon-ifn","safety":{"commonSideEffects":[{"rate":"50-70%","effect":"Flu-like symptoms"},{"rate":"30-50%","effect":"Fatigue"},{"rate":"20-40%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108510","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Interferon-β is a type I interferon that plays a key role in the innate immune response, particularly in the activation of macrophages and the induction of antiviral and antiproliferative proteins.","oneSentence":"Interferon-β binds to the interferon receptor, activating a signaling cascade that modulates the immune response.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:37:18.025Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Multiple Sclerosis"},{"name":"Relapsing-Remitting Multiple Sclerosis"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9002,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Avonex®","Rebif®","Betaseron®"],"phase":"phase_2","status":"active","brandName":"Interferon-β [IFN-β]","genericName":"Interferon-β [IFN-β]","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Interferon-β binds to the interferon receptor, activating a signaling cascade that modulates the immune response. Used for Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}